ARESTAT Trademark

Trademark Overview

On Tuesday, September 28, 2021, a trademark application was filed for ARESTAT with the United States Patent and Trademark Office. The USPTO has given the ARESTAT trademark a serial number of 79327650. The federal status of this trademark filing is REGISTERED as of Tuesday, July 4, 2023. This trademark is owned by Arecor Limited. The ARESTAT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines
arestat

General Information

Serial Number79327650
Word MarkARESTAT
Filing DateTuesday, September 28, 2021
Status700 - REGISTERED
Status DateTuesday, July 4, 2023
Registration Number7095326
Registration DateTuesday, July 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesMedical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArecor Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameArecor Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameArecor Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 4, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 4, 2023REGISTERED-PRINCIPAL REGISTER
Monday, May 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 19, 2023NOTIFICATION PROCESSED BY IB
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 29, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 23, 2023ATTORNEY REVIEW COMPLETED
Monday, January 23, 2023LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, December 19, 2022LIMITATION OF GOODS RECEIVED FROM IB
Monday, October 3, 2022REFUSAL PROCESSED BY IB
Wednesday, September 14, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 13, 2022REFUSAL PROCESSED BY MPU
Friday, August 5, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 4, 2022NON-FINAL ACTION WRITTEN
Thursday, July 28, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, June 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 29, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Tuesday, December 14, 2021APPLICATION FILING RECEIPT MAILED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

arestat development research pharmaceutical medicines product evaluation vaccines preparations pharmacological consultancy